Imaging Degeneration of the Substantia Nigra in Parkinson Disease with Inversion-Recovery MR Imaging

References

1. ↵
   Elkeslassy A, Miaux Y, Martin-Duverneuil N, et al. MRI of degenerative extrapyramidal syndromes: Parkinson disease, progressive supranuclear palsy and multiple system atrophy. J Neuroradiol. 1996;23:157–63

   PubMed
2. ↵
   Ravina B, Eidelberg D, Ahlskog JE, et al. The role of radiotracer imaging in Parkinson disease. Neurology 2005;64:208–15

   Abstract/FREE Full Text
3. ↵
   Ordidge RJ, Gorell JM, Deniau JC, et al. Assessment of relative brain iron concentrations using T2-weighted and T2*-weighted MRI at 3 Tesla. Magn Reson Med 1994;32:335–41

   PubMedWeb of Science
4. ↵
   Gorell JM, Ordidge RJ, Brown GG, et al. Increased iron-related MRI contrast in the substantia nigra in Parkinson’s disease. Neurology 1995;45:1138–43

   Abstract/FREE Full Text
5. ↵
   Graham JM, Paley MN, Grunewald RA, et al. Brain iron deposition in Parkinson’s disease imaged using the PRIME magnetic resonance sequence. Brain 2000;123:2423–31

   Abstract/FREE Full Text
6. ↵
   Oikawa H, Sasaki M, Tamakawa Y, et al. The substantia nigra in Parkinson disease: proton density-weighted spin-echo and fast short inversion time inversion-recovery MR findings. AJNR Am J Neuroradiol 2002;23:1747–56

   Abstract/FREE Full Text
7. ↵
   Adachi M, Hosoya T, Haku T, et al. Evaluation of the substantia nigra in patients with Parkinsonian syndrome accomplished using multishot diffusion-weighted MR imaging. AJNR Am J Neuroradiol 1999;20:1500–06

   Abstract/FREE Full Text
8. ↵
   Yoshikawa K, Nakata Y, Yamada K, et al. Early pathological changes in the parkinsonian brain demonstrated by diffusion tensor MRI. J Neurol Neurosurg Psychiatry 2004;75:481–84

   Abstract/FREE Full Text
9. Seppi K, Schocke MF, Esterhammer R, et al. Diffusion-weighted imaging discriminates progressive supranuclear palsy from PD, but not from the parkinson variant of multiple system atrophy. Neurology 2003;60:922–27

   Abstract/FREE Full Text
10. ↵
    Schocke MF, Seppi K, Esterhammer R, et al. Trace of diffusion tensor differentiates the Parkinson variant of multiple system atrophy and Parkinson’s disease. Neuroimage 2004;21:1443–51

    CrossRefPubMedWeb of Science
11. ↵
    Hutchinson M, Raff U, Lebedev S. MRI correlates of pathology in parkinsonism: segmented inversion recovery ratio imaging (SIRRIM). Neuroimage 2003;20:1899–902

    PubMed
12. ↵
    Hutchinson M, Raff U. Structural changes of the substantia nigra in Parkinson’s disease as revealed by MR imaging. AJNR Am J Neuroradiol 2000;21:697–701

    Abstract/FREE Full Text
13. ↵
    Hutchinson M, Raff U. Parkinson’s disease: a novel MRI method for determining structural changes in the substantia nigra. J Neurol Neurosurg Psychiatry 1999;69:815–18
14. ↵
    Gelb DJ, Oliver E, Gilman S. Diagnostic criteria for Parkinson disease. Arch Neurol 1999;6:33–39
15. ↵
    Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology 1967;17:427–42

    FREE Full Text
16. ↵
    Hendrick ER. Image contrast and noise. In: Stark DD, Bradley WG, eds. Magnetic Resonance Imaging. Philadelphia: Mosby;1996;53–7
17. ↵
    Olszewski J, Baxter D. Cytoarchitecture of the Human Brain Stem. S. Karker: New York;1954;50 , 52–56, 58, 60, 131, 132
18. ↵
    Duvernoy HM, Vannson JL. Human Brain Stem and Cerebellum: Surface, Structure, Vascularization, and Three-Dimensional Sectional Anatomy with MRI. Berlin, Germany: Springer-Verlag;1995;34–50, 70–75
19. ↵
    Van Buren JM, Borke RC. Variations of the human diencephalon. Berlin, Germany: Springer-Verlag;1972;34–7
20. ↵
    Vymazal J, Righini A, Brooks RA, et al. T1 and T2 in the brain of healthy subjects, patients with Parkinson disease, and patients with multiple system atrophy: relation to iron content. Radiology 1999;211:489–95

    PubMedWeb of Science
21. ↵
    Graham DI, Lantos PL. Greenfield’s Neuropathology. Vol.2 . Hodder Arnold: London, UK;2002;329–50